Israel - English - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - bcg strain - powder for solution for instillation - bcg strain 200 - 800 miu - bcg vaccine - bcg vaccine - oncotice is used as a treatment of flat urothelial cell carcinoma in situ (cis) of the bladder and as an adjuvant therapy after transurethral resection (tur) of a primary or relapsing superficial papillary urothelial cell carcinoma of the bladder stage ta (grade 2 or 3) or t1 (grade 1 2 or 3). oncotice is only recommended for stage ta grade 1 papillary tumors when there is judged to be a high risk of tumor recurrence.

Israel - English - Ministry of Health

eli lilly israel ltd, israel - ramucirumab - concentrate for solution for infusion - ramucirumab 10 mg/ml - ramucirumab - gastric cancercyramza in combination with paclitaxel is indicated for the treatment of adult patients with advanced gastric cancer or gastro-oesophageal junction adenocarcinoma with disease progression after prior platinum and fluoropyrimidine chemotherapy. cyramza monotherapy is indicated for the treatment of adult patients with advanced gastric cancer or gastro-oesophageal junction adenocarcinoma with disease progression after prior platinum or fluoropyrimidine chemotherapy, for whom treatment in combination with paclitaxel is not appropriate.colorectal cancercyramza, in combination with folfiri (irinotecan, folinic acid, and 5-fluorouracil), is indicated for the treatment of adult patients with metastatic colorectal cancer (mcrc) with disease progression on or after prior therapy with bevacizumab, oxaliplatin and a fluoropyrimidine.non-small cell lung cancercyramza in combination with erlotinib is indicated for the first-line treatment of adult patients with metastatic non-small cell lung adenocarcinoma with activating epidermal growth factor receptor (egfr) mutations.cyramza in combination with docetaxel is indicated for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer with disease progression after platinum-based chemotherapy.hepatocellular carcinomacyramza monotherapy is indicated for the treatment of adult patients with advanced or unresectable hepatocellular carcinoma who have a serum alpha fetoprotein (afp) of ≥ 400 ng/ml and who have been previously treated with sorafenib.

United States - English - NLM (National Library of Medicine)

ltd enterprises distribution, inc. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic hand sanitizer to help reduce bacteria that potentially can cause disease. for use when soap and water are not available. stop use and ask a doctor if irritation or redness develops and lasts as these may be signs of a serious condition.

Australia - English - Department of Health (Therapeutic Goods Administration)

mentholatum australasia pty ltd - menthol,methyl salicylate -

Malta - English - Medicines Authority

the mentholatum company limited 1 redwood avenue, peel park campus, east kilbride, g74 5pe, scotland, united kingdom - camphor, methyl salicylate, menthol - ointment - camphor 9 percent weight/weight ; methyl salicylate 0.33 percent weight/weight ; menthol 1.35 percent weight/weight - topical products for joint and muscular pain

Canada - English - Health Canada

the mentholatum company of canada ltd - eucalyptus oil; menthol - lozenge - .3%; .4% - eucalyptus oil .3%; menthol .4% - other cold and cough preparations

Canada - English - Health Canada

the mentholatum company of canada ltd - eucalyptus oil; menthol; camphor - ointment - 1.3%; 2.8%; 5% - eucalyptus oil 1.3%; menthol 2.8%; camphor 5% - other cold and cough preparations

Canada - English - Health Canada

the mentholatum company of canada ltd - octisalate; octinoxate - ointment - 5%; 7.5% - octisalate 5%; octinoxate 7.5% - sunscreen agents

Canada - English - Health Canada

the mentholatum company of canada ltd - octisalate; octinoxate - ointment - 5%; 7.5% - octisalate 5%; octinoxate 7.5% - sunscreen agents

Canada - English - Health Canada

the mentholatum company of canada ltd - padimate o - ointment - 1.5% - padimate o 1.5% - sunscreen agents